SEARCH

SEARCH BY CITATION

  • 1
    Wheler, JJ, Tsimberidou, AM, Hong, DS, et al. Risk of serious toxicity in 1181 patients treated in phase 1 clinical trials of predominantly targeted anticancer drugs: the MD Anderson Cancer Center experience. Ann Oncol. 2012; 23:1963-1967.